TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionLPL Financial LLC
Latest Disclosed Ownership94,426 shares
Latest Disclosed Value $ 3,136,832
LPL Financial LLC reports 2.18% decrease in ownership of 1TGTX / TG Therapeutics, Inc.

On May 6, 2026 - LPL Financial LLC filed a 13F-HR form disclosing ownership of 94,426 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $2,611,823 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 96,533 shares of TG Therapeutics, Inc.. This represents a change in shares of -2.18% during the quarter. The current value of the position is $3,210,484 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 94,426 -2,107 -2.18 3,137 9.00 0.0008
2026-02-11 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 96,533 -38,046 -28.27 2,878 -40.81 0.0008
2025-11-12 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 134,579 -30,524 -18.49 4,862 -18.19 0.0014
2025-08-12 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 165,103 -19,960 -10.79 5,942 -18.57 0.0020
2025-05-07 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 185,063 1 0.00 7,297 31.01 0.0028
2025-02-11 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 185,062 70,740 61.88 5,570 108.38 0.0023
2024-11-08 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 114,322 -18,958 -14.22 2,674 12.74 0.0012
2024-08-07 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 133,280 18,778 16.40 2,371 36.19 0.0012
2024-05-10 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 114,502 21,934 23.70 1,742 10.12 0.0009
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 92,568 1,180 1.29 1,581 106.94 0.0010
2023-11-13 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 91,388 24,230 36.08 764 -54.20 0.0005
2023-07-31 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 67,158 17,010 33.92 1,668 121.22 0.0012
2023-05-10 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 50,148 11,293 29.06 754 64.27 0.0006
2023-02-07 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 38,855 11,480 41.94 460 183.33 0.0004
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 27,375 -1,265 -4.42 162 32.79 0.0002
2022-08-12 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 28,640 -1,286 -4.30 122 -57.19 0.0001
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 29,926 2,632 9.64 285 -45.09 0.0002
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 27,294 461 1.72 519 -41.88 0.0004
2021-11-15 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 26,833 7,476 38.62 893 18.91 0.0008
2021-08-13 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 19,357 7,909 69.09 751 36.05 0.0008
2021-05-14 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 11,448 -8,936 -43.84 552 -47.92 0.0006
2021-02-12 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 20,384 5,999 41.70 1,060 175.32 0.0014
2020-11-09 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 14,385 81 0.57 385 37.99 0.0006
2020-08-13 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 14,304 985 7.40 279 112.98 0.0005
2020-05-14 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 13,319 -677 -4.84 131 -15.48 0.0003
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 13,996 2,233 18.98 155 134.85 0.0003
2019-11-13 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 11,763 -175 -1.47 66 -35.92 0.0001
2019-08-09 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 11,938 309 2.66 103 10.75 0.0002
2019-05-08 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 11,629 -283 -2.38 93 89.80 0.0002
2019-02-07 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 11,912 11,912 49 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.